The company has completely zero debt and trading way under Cash on hand.Not to mention that Celebrex(Pfizer Drug) has major risks while kitov has an improved Celebrex .folks might drop Celebrex overnight and switch to Kitov drug and not worry about side affects. with the improved celebrex Pfizer could easily pass $2.4B even $3B sales IMO. also analysts predicted a blockbaster potential in the US alone.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM